Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).

 Vectura GroupMedical Developments InternationalMayne Pharma GroupEco Animal Health GroupBEXIMCO PHARMAC/S GDR REGS
Price Information
Current PriceGBX 81.05A$6.10A$0.49GBX 406GBX 43
52 Week RangeBuyN/AN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyN/AN/ABuyBuy
Consensus Price TargetGBX 122.86N/AN/AGBX 600N/A
% Upside from Price Target51.58% upsideN/AN/A47.78% upsideN/A
Trade Information
Market Cap£540.04 million$399.65 million$767.73 million£273.51 million£174.39 million
Average Volume4,610,000N/A6,320,00039,51235,555
Sales & Book Value
Annual Revenue£160.50 million$19.18 million$561.43 million£74.58 millionN/A
Price / Sales3.3620.841.373.67N/A
CashflowGBX 15.78 per shareA$0.50 per shareA$0.06 per shareGBX 26.64 per shareN/A
Price / Cash5.1412.118.5715.24N/A
Book ValueGBX 74.50 per shareA$0.70 per shareA$0.82 per shareGBX 159.70 per shareN/A
Price / Book0.018.700.600.03N/A
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (13.20)A$0.00A$0.03GBX 17.30N/A
Trailing P/E RatioN/A1,525.0015.6523.470.00
Forward P/E Ratio
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutN/AA$0.04N/AGBX 0.15GBX 0.01
Dividend YieldN/A0.66%N/A0.04%0.02%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A1,000.00%N/A0.87%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.81%0.62%30.42%1.76%38.08%
Current Ratio2.35%4.52%1.99%4.09%1.17%
Quick Ratio1.90%4.13%1.52%3.04%0.36%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding666.30 million65.52 million1.58 billion67.37 million405.56 million
Next Earnings DateN/AN/A8/23/2019 (Estimated)N/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Vectura GroupMedical Developments InternationalMayne Pharma GroupEco Animal Health GroupBEXIMCO PHARMAC/S GDR REGS

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel